Integrating Wi-Fi and cellular may also create some network security challenges, Kumar says. “Consider for example, the cellular network providing a gateway for malicious users to access into a ...

The network is called Lunar Surface Communication System (LSCS), and it is basically a replica of the 4G/LTE cellular technology currently used on a very large scale by the humans of Earth.

AST SpaceMobile, which aims to build a space-based cellular broadband network accessible by everyday smartphones, has announced $460m of debt funding. It estimates that the net proceeds from the ...

In his book The Mathematical Universe, mathematician William Dunham wrote of John Venn’s namesake legacy, the Venn diagram, “No one in the long history of mathematics ever became better known ...

31 (UPI) --The Department of Justice sued Thursday to block the $14 billion Hewlett ... the second- and third-largest providers of wireless local area network technology respectively, would ...

Excalidraw is an innovative online whiteboarding tool that uses the power of artificial intelligence (AI) to convert simple text prompts into detailed, professional-quality diagrams. Whether you ...

Good earbuds are one thing, but the Sennheiser Accentum True Wireless Earbuds take things ... They offer hybrid active noise cancellation (ANC) to block out distractions and keep you focused ...

Hence, researchers often simulate the brain as a network of coupled neural masses, each described by a mean-field model. These models capture the essential features of neuronal populations while ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will ...